Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database

• Yoojin Noh,

  Affiliation College of Pharmacy, Ajou University, Suwon, South Korea

  ⨯
• Jimin Lee,

  Affiliation College of Pharmacy, Ajou University, Suwon, South Korea

  ⨯
• Sooyoung Shin,

  Affiliation College of Pharmacy, Ajou University, Suwon, South Korea

  ⨯
• Hong-Seok Lim,

  Affiliation Department of Cardiology, School of Medicine, Ajou University, Suwon, South Korea

  ⨯
• Soo Kyung Bae,

  Affiliation College of Pharmacy, The Catholic University of Korea, Bucheon, South Korea

  ⨯
• Euichul Oh,

  Affiliation College of Pharmacy, The Catholic University of Korea, Bucheon, South Korea

  ⨯
• Grace Juyun Kim,

  Affiliation Division of Biomedical Informatics, College of Medicine, Seoul National University, Seoul, South Korea

  ⨯
• Ju Han Kim,

  Affiliation Division of Biomedical Informatics, College of Medicine, Seoul National University, Seoul, South Korea

  ⨯
• Sukhyang Lee

  * E-mail: suklee@ajou.ac.kr

  Affiliation College of Pharmacy, Ajou University, Suwon, South Korea

  ⨯